abstract |
The invention provides a combination of biomarkers for diagnosing non-obstructive azoospermia, which comprises FGF1, FGF9 and FGF14, and can be used for preparing an ELISA detection kit, and the diagnosis of the non-obstructive azoospermia is carried out by detecting the expression conditions of FGF1, FGF9 and FGF14 in a blood sample of a patient, so that the pain of the patient can be greatly relieved, and the combination has a wide application prospect. |